🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/04/2014 36,69 37,24 36,26 37,13 +0,05% 2,67% 615.300
29/04/2014 36,30 37,58 36,24 37,11 +2,06% 3,69% 848.400
28/04/2014 37,91 38,25 35,18 36,36 -0,93% 8,10% 1.412.200
25/04/2014 37,37 38,13 36,36 36,70 -3,90% 4,74% 1.257.900
24/04/2014 38,50 38,77 36,51 38,19 -1,85% 5,87% 3.172.100
23/04/2014 37,59 39,81 37,26 38,91 +0,31% 6,78% 2.823.900
22/04/2014 34,56 39,20 34,50 38,79 +14,16% 13,60% 4.306.800
21/04/2014 40,00 40,00 33,57 33,98 +39,26% 16,08% 13.109.300
17/04/2014 24,01 24,74 23,42 24,40 +0,70% 5,50% 1.001.300
16/04/2014 22,89 24,25 22,89 24,23 +6,88% 5,94% 885.600
15/04/2014 22,50 23,20 20,89 22,67 +1,70% 10,27% 1.046.900
14/04/2014 22,41 23,42 21,56 22,29 +0,50% 8,30% 1.228.400
11/04/2014 22,87 23,58 22,00 22,18 -4,48% 6,91% 1.282.800
10/04/2014 25,86 26,00 23,09 23,22 -10,00% 11,25% 1.525.400
09/04/2014 25,25 26,11 25,20 25,80 +3,66% 3,60% 1.124.600
08/04/2014 24,90 25,76 23,75 24,89 +0,65% 8,07% 1.661.100
07/04/2014 22,98 25,41 21,75 24,73 +7,29% 15,93% 2.211.200
04/04/2014 24,42 24,69 22,53 23,05 -4,99% 8,85% 985.800
03/04/2014 25,17 25,75 23,75 24,26 -3,81% 7,95% 772.400
02/04/2014 26,14 26,45 25,07 25,22 -1,91% 5,28% 924.900
01/04/2014 24,26 25,98 24,26 25,71 +6,99% 7,09% 903.200
31/03/2014 23,76 24,40 23,31 24,03 +2,12% 4,59% 573.400
28/03/2014 23,70 24,15 23,15 23,53 -0,84% 4,22% 943.600
27/03/2014 22,86 24,25 22,35 23,73 +3,22% 8,31% 1.022.600
26/03/2014 24,24 24,38 22,49 22,99 -4,05% 7,80% 1.087.500
25/03/2014 24,80 25,35 23,70 23,96 -2,36% 6,65% 810.100
24/03/2014 26,63 27,00 23,52 24,54 -7,74% 13,07% 1.482.900
21/03/2014 28,34 28,45 26,54 26,60 -4,80% 6,74% 1.721.900
20/03/2014 28,49 29,00 27,70 27,94 -2,55% 4,56% 485.200
19/03/2014 28,20 28,96 27,51 28,67 +1,85% 5,14% 903.900